{"id":"https://openalex.org/W2145854263","doi":"https://doi.org/10.1158/1078-0432.ccr-1100-03","title":"Antitumor Activity of ZD6474, a Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, in Human Cancer Cells with Acquired Resistance to Antiepidermal Growth Factor Receptor Therapy","display_name":"Antitumor Activity of ZD6474, a Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, in Human Cancer Cells with Acquired Resistance to Antiepidermal Growth Factor Receptor Therapy","publication_year":2004,"publication_date":"2004-01-15","ids":{"openalex":"https://openalex.org/W2145854263","doi":"https://doi.org/10.1158/1078-0432.ccr-1100-03","mag":"2145854263","pmid":"https://pubmed.ncbi.nlm.nih.gov/14760102"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.ccr-1100-03","doi":"https://doi.org/10.1158/1078-0432.ccr-1100-03","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-1100-03","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5056034569","display_name":"Fortunato Ciardiello","orcid":"https://orcid.org/0000-0002-3369-4841","observed_orcids":["https://orcid.org/0000-0002-3369-4841"]},"institutions":[{"id":"https://openalex.org/I197809005","display_name":"University of Campania \"Luigi Vanvitelli\"","ror":"https://ror.org/02kqnpp86","country_code":"IT","type":"education","lineage":["https://openalex.org/I197809005"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Fortunato Ciardiello","raw_affiliation_strings":["1Cattedra di Oncologia Medica, Dipartimento Medico-Chirurgico di Internistica Clinica e Sperimentale \u201cF Magrassi e A Lanzara,\u201d Seconda Universita\u0300 degli Studi di Napoli, Naples, Italy, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Cattedra di Oncologia Medica, Dipartimento Medico-Chirurgico di Internistica Clinica e Sperimentale \u201cF Magrassi e A Lanzara,\u201d Seconda Universita\u0300 degli Studi di Napoli, Naples, Italy, and","institution_ids":["https://openalex.org/I197809005"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040413764","display_name":"Roberto Bianco","orcid":"https://orcid.org/0000-0003-3311-260X","observed_orcids":["https://orcid.org/0000-0003-3311-260X"]},"institutions":[{"id":"https://openalex.org/I71267560","display_name":"University of Naples Federico II","ror":"https://ror.org/05290cv24","country_code":"IT","type":"education","lineage":["https://openalex.org/I71267560"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Roberto Bianco","raw_affiliation_strings":["2Cattedra di Oncologia Medica, Dipartimento di Endocrinologia e Oncologia Molecolare e Clinica, Universita\u0300 degli Studi di Napoli Federico II, Naples, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Cattedra di Oncologia Medica, Dipartimento di Endocrinologia e Oncologia Molecolare e Clinica, Universita\u0300 degli Studi di Napoli Federico II, Naples, Italy","institution_ids":["https://openalex.org/I71267560"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110249663","display_name":"Roberta Caputo","orcid":"https://orcid.org/0000-0003-4231-1184","observed_orcids":["https://orcid.org/0000-0003-4231-1184"]},"institutions":[{"id":"https://openalex.org/I71267560","display_name":"University of Naples Federico II","ror":"https://ror.org/05290cv24","country_code":"IT","type":"education","lineage":["https://openalex.org/I71267560"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Roberta Caputo","raw_affiliation_strings":["2Cattedra di Oncologia Medica, Dipartimento di Endocrinologia e Oncologia Molecolare e Clinica, Universita\u0300 degli Studi di Napoli Federico II, Naples, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Cattedra di Oncologia Medica, Dipartimento di Endocrinologia e Oncologia Molecolare e Clinica, Universita\u0300 degli Studi di Napoli Federico II, Naples, Italy","institution_ids":["https://openalex.org/I71267560"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110188292","display_name":"Rosa Caputo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I71267560","display_name":"University of Naples Federico II","ror":"https://ror.org/05290cv24","country_code":"IT","type":"education","lineage":["https://openalex.org/I71267560"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Rosa Caputo","raw_affiliation_strings":["2Cattedra di Oncologia Medica, Dipartimento di Endocrinologia e Oncologia Molecolare e Clinica, Universita\u0300 degli Studi di Napoli Federico II, Naples, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Cattedra di Oncologia Medica, Dipartimento di Endocrinologia e Oncologia Molecolare e Clinica, Universita\u0300 degli Studi di Napoli Federico II, Naples, Italy","institution_ids":["https://openalex.org/I71267560"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110448318","display_name":"Vincenzo Damiano","orcid":"https://orcid.org/0009-0004-4249-9804","observed_orcids":["https://orcid.org/0009-0004-4249-9804"]},"institutions":[{"id":"https://openalex.org/I71267560","display_name":"University of Naples Federico II","ror":"https://ror.org/05290cv24","country_code":"IT","type":"education","lineage":["https://openalex.org/I71267560"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Vincenzo Damiano","raw_affiliation_strings":["2Cattedra di Oncologia Medica, Dipartimento di Endocrinologia e Oncologia Molecolare e Clinica, Universita\u0300 degli Studi di Napoli Federico II, Naples, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Cattedra di Oncologia Medica, Dipartimento di Endocrinologia e Oncologia Molecolare e Clinica, Universita\u0300 degli Studi di Napoli Federico II, Naples, Italy","institution_ids":["https://openalex.org/I71267560"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020655022","display_name":"Teresa Troiani","orcid":"https://orcid.org/0000-0002-0646-4901","observed_orcids":["https://orcid.org/0000-0002-0646-4901"]},"institutions":[{"id":"https://openalex.org/I71267560","display_name":"University of Naples Federico II","ror":"https://ror.org/05290cv24","country_code":"IT","type":"education","lineage":["https://openalex.org/I71267560"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Teresa Troiani","raw_affiliation_strings":["2Cattedra di Oncologia Medica, Dipartimento di Endocrinologia e Oncologia Molecolare e Clinica, Universita\u0300 degli Studi di Napoli Federico II, Naples, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Cattedra di Oncologia Medica, Dipartimento di Endocrinologia e Oncologia Molecolare e Clinica, Universita\u0300 degli Studi di Napoli Federico II, Naples, Italy","institution_ids":["https://openalex.org/I71267560"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049680516","display_name":"Davide Melisi","orcid":"https://orcid.org/0000-0002-4031-7585","observed_orcids":["https://orcid.org/0000-0002-4031-7585"]},"institutions":[{"id":"https://openalex.org/I71267560","display_name":"University of Naples Federico II","ror":"https://ror.org/05290cv24","country_code":"IT","type":"education","lineage":["https://openalex.org/I71267560"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Davide Melisi","raw_affiliation_strings":["2Cattedra di Oncologia Medica, Dipartimento di Endocrinologia e Oncologia Molecolare e Clinica, Universita\u0300 degli Studi di Napoli Federico II, Naples, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Cattedra di Oncologia Medica, Dipartimento di Endocrinologia e Oncologia Molecolare e Clinica, Universita\u0300 degli Studi di Napoli Federico II, Naples, Italy","institution_ids":["https://openalex.org/I71267560"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009130863","display_name":"Ferdinando De Vita","orcid":"https://orcid.org/0000-0002-7654-7470","observed_orcids":["https://orcid.org/0000-0002-7654-7470"]},"institutions":[{"id":"https://openalex.org/I197809005","display_name":"University of Campania \"Luigi Vanvitelli\"","ror":"https://ror.org/02kqnpp86","country_code":"IT","type":"education","lineage":["https://openalex.org/I197809005"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Ferdinando De Vita","raw_affiliation_strings":["1Cattedra di Oncologia Medica, Dipartimento Medico-Chirurgico di Internistica Clinica e Sperimentale \u201cF Magrassi e A Lanzara,\u201d Seconda Universita\u0300 degli Studi di Napoli, Naples, Italy, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Cattedra di Oncologia Medica, Dipartimento Medico-Chirurgico di Internistica Clinica e Sperimentale \u201cF Magrassi e A Lanzara,\u201d Seconda Universita\u0300 degli Studi di Napoli, Naples, Italy, and","institution_ids":["https://openalex.org/I197809005"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078562748","display_name":"Sabino De Placido","orcid":"https://orcid.org/0000-0001-5077-6286","observed_orcids":["https://orcid.org/0000-0001-5077-6286"]},"institutions":[{"id":"https://openalex.org/I71267560","display_name":"University of Naples Federico II","ror":"https://ror.org/05290cv24","country_code":"IT","type":"education","lineage":["https://openalex.org/I71267560"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Sabino De Placido","raw_affiliation_strings":["2Cattedra di Oncologia Medica, Dipartimento di Endocrinologia e Oncologia Molecolare e Clinica, Universita\u0300 degli Studi di Napoli Federico II, Naples, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Cattedra di Oncologia Medica, Dipartimento di Endocrinologia e Oncologia Molecolare e Clinica, Universita\u0300 degli Studi di Napoli Federico II, Naples, Italy","institution_ids":["https://openalex.org/I71267560"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109233132","display_name":"A R Bianco","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I71267560","display_name":"University of Naples Federico II","ror":"https://ror.org/05290cv24","country_code":"IT","type":"education","lineage":["https://openalex.org/I71267560"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"A. Raffaele Bianco","raw_affiliation_strings":["2Cattedra di Oncologia Medica, Dipartimento di Endocrinologia e Oncologia Molecolare e Clinica, Universita\u0300 degli Studi di Napoli Federico II, Naples, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Cattedra di Oncologia Medica, Dipartimento di Endocrinologia e Oncologia Molecolare e Clinica, Universita\u0300 degli Studi di Napoli Federico II, Naples, Italy","institution_ids":["https://openalex.org/I71267560"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5050215401","display_name":"Giampaolo Tortora","orcid":"https://orcid.org/0000-0002-1378-4962","observed_orcids":["https://orcid.org/0000-0002-1378-4962"]},"institutions":[{"id":"https://openalex.org/I71267560","display_name":"University of Naples Federico II","ror":"https://ror.org/05290cv24","country_code":"IT","type":"education","lineage":["https://openalex.org/I71267560"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Giampaolo Tortora","raw_affiliation_strings":["2Cattedra di Oncologia Medica, Dipartimento di Endocrinologia e Oncologia Molecolare e Clinica, Universita\u0300 degli Studi di Napoli Federico II, Naples, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Cattedra di Oncologia Medica, Dipartimento di Endocrinologia e Oncologia Molecolare e Clinica, Universita\u0300 degli Studi di Napoli Federico II, Naples, Italy","institution_ids":["https://openalex.org/I71267560"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":10.8333,"has_fulltext":false,"cited_by_count":345,"citation_normalized_percentile":{"value":0.99410379,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":100},"biblio":{"volume":"10","issue":"2","first_page":"784","last_page":"793"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.7134000062942505,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.7134000062942505,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.2117999941110611,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.03229999914765358,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vegfr-tyrosine-kinase-inhibitors","display_name":"VEGFR inhibitors","score":0.7749999761581421},{"id":"https://openalex.org/keywords/vegfr2","display_name":"VEGFR2","score":0.8999999761581421},{"id":"https://openalex.org/keywords/egfr-inhibitors","display_name":"EGFR inhibitors","score":0.6340000033378601},{"id":"https://openalex.org/keywords/gefitinib","display_name":"gefitinib","score":0.8519999980926514},{"id":"https://openalex.org/keywords/cetuximab","display_name":"cetuximab","score":0.9940000176429749},{"id":"https://openalex.org/keywords/acquired-drug-resistance","display_name":"acquired drug resistance","score":0.8949999809265137},{"id":"https://openalex.org/keywords/colon-cancer","display_name":"colon cancer","score":0.5979999899864197},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.8640000224113464},{"id":"https://openalex.org/keywords/egfr-tyrosine-kinase","display_name":"EGFR tyrosine kinase","score":0.6589999794960022},{"id":"https://openalex.org/keywords/tumor-angiogenesis","display_name":"tumor angiogenesis","score":0.5659999847412109},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.5929999947547913}],"concepts":[{"id":"https://openalex.org/C2780580887","wikidata":"https://www.wikidata.org/wiki/Q417824","display_name":"Gefitinib","level":4,"score":0.7504289746284485},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6633998155593872},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.6435069441795349},{"id":"https://openalex.org/C2779998722","wikidata":"https://www.wikidata.org/wiki/Q420296","display_name":"Cetuximab","level":4,"score":0.6002748608589172},{"id":"https://openalex.org/C128240485","wikidata":"https://www.wikidata.org/wiki/Q786998","display_name":"Autocrine signalling","level":3,"score":0.5907222628593445},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.5504027605056763},{"id":"https://openalex.org/C2776362946","wikidata":"https://www.wikidata.org/wiki/Q424374","display_name":"Epidermal growth factor","level":3,"score":0.5264697074890137},{"id":"https://openalex.org/C2777506169","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"EGFR inhibitors","level":4,"score":0.5187318921089172},{"id":"https://openalex.org/C130287650","wikidata":"https://www.wikidata.org/wiki/Q17091190","display_name":"Growth factor receptor inhibitor","level":4,"score":0.5109907388687134},{"id":"https://openalex.org/C2777025900","wikidata":"https://www.wikidata.org/wiki/Q29725","display_name":"Vascular endothelial growth factor","level":3,"score":0.5060731768608093},{"id":"https://openalex.org/C26375932","wikidata":"https://www.wikidata.org/wiki/Q118226","display_name":"Growth factor receptor","level":3,"score":0.4419841766357422},{"id":"https://openalex.org/C101544691","wikidata":"https://www.wikidata.org/wiki/Q420511","display_name":"Receptor tyrosine kinase","level":3,"score":0.42571622133255005},{"id":"https://openalex.org/C180361614","wikidata":"https://www.wikidata.org/wiki/Q7202242","display_name":"Platelet-derived growth factor receptor","level":4,"score":0.42280229926109314},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4220055937767029},{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.4136899411678314},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.39308035373687744},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3813621997833252},{"id":"https://openalex.org/C2775960820","wikidata":"https://www.wikidata.org/wiki/Q408378","display_name":"Growth factor","level":3,"score":0.2916688323020935},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2641085982322693},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.24573808908462524},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.2297067940235138},{"id":"https://openalex.org/C167734588","wikidata":"https://www.wikidata.org/wiki/Q4356503","display_name":"VEGF receptors","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000068818","descriptor_name":"Cetuximab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D000362","descriptor_name":"Agar","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002455","descriptor_name":"Cell Division","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002462","descriptor_name":"Cell Membrane","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003110","descriptor_name":"Colonic Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005434","descriptor_name":"Flow Cytometry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008807","descriptor_name":"Mice, Inbred BALB C","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009368","descriptor_name":"Neoplasm Transplantation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011233","descriptor_name":"Precipitin Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011799","descriptor_name":"Quinazolines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015153","descriptor_name":"Blotting, Western","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D040262","descriptor_name":"Receptors, Vascular Endothelial Growth Factor","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1158/1078-0432.ccr-1100-03","doi":"https://doi.org/10.1158/1078-0432.ccr-1100-03","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-1100-03","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},{"id":"pmid:14760102","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/14760102","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Journal Article"},{"id":"pmh:oai:iris.unicampania.it:11591/235288","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/11591/235288","pdf_url":null,"source":{"id":"https://openalex.org/S7407055255","display_name":"Archivio Istituzionale della Ricerca - Universit\u00e0 degli Studi della Campania \"Luigi Vanvitelli\"","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":46,"referenced_works":["https://openalex.org/W1590794385","https://openalex.org/W1592193248","https://openalex.org/W1804903119","https://openalex.org/W1876325581","https://openalex.org/W1913061990","https://openalex.org/W1939364580","https://openalex.org/W1945415917","https://openalex.org/W1974165456","https://openalex.org/W1991958278","https://openalex.org/W1994953133","https://openalex.org/W2001453148","https://openalex.org/W2010174111","https://openalex.org/W2049938167","https://openalex.org/W2057458801","https://openalex.org/W2060630008","https://openalex.org/W2064047613","https://openalex.org/W2064360454","https://openalex.org/W2074312161","https://openalex.org/W2079668582","https://openalex.org/W2098544382","https://openalex.org/W2103745379","https://openalex.org/W2111060860","https://openalex.org/W2116150263","https://openalex.org/W2116864064","https://openalex.org/W2118146357","https://openalex.org/W2118559000","https://openalex.org/W2126314379","https://openalex.org/W2129477954","https://openalex.org/W2130461015","https://openalex.org/W2130840817","https://openalex.org/W2131362842","https://openalex.org/W2133138712","https://openalex.org/W2135374295","https://openalex.org/W2140167336","https://openalex.org/W2142525191","https://openalex.org/W2142661339","https://openalex.org/W2143378100","https://openalex.org/W2143536404","https://openalex.org/W2148122132","https://openalex.org/W2151808807","https://openalex.org/W2154897272","https://openalex.org/W2155180567","https://openalex.org/W2155977433","https://openalex.org/W2163402367","https://openalex.org/W2164686711","https://openalex.org/W2171685800"],"related_works":["https://openalex.org/W2116864064","https://openalex.org/W2014383618","https://openalex.org/W2346640639","https://openalex.org/W4317613968","https://openalex.org/W2507242962","https://openalex.org/W2623617857","https://openalex.org/W2090699402","https://openalex.org/W2339174755","https://openalex.org/W2097991473","https://openalex.org/W2808177954"],"abstract_inverted_index":{"PURPOSE:":[0],"The":[1,44,117],"epidermal":[2],"growth":[3,72,180,211,244,270,294,365,412],"factor":[4,73,366],"receptor":[5],"(EGFR)":[6],"autocrine":[7],"signaling":[8,173,471],"pathway":[9],"is":[10,75,96],"involved":[11,169],"in":[12,40,51,66,85,127,149,170,212,241,261,298,308,342,357,391,397,415,446,479],"cancer":[13,48,68,78,134,452],"development":[14,448],"and":[15,29,80,93,123,331,384,396,402,410],"progression.":[16],"EGFR":[17,56,112,141,159,279,286,336,362,443,450,456],"inhibitors":[18,57,142,287,444],"such":[19],"as":[20,327,413,474],"C225":[21,204,312,321,426],"(cetuximab),":[22],"a":[23,32,82,97,388],"chimeric":[24],"human-mouse":[25],"anti-EGFR":[26],"monoclonal":[27],"antibody,":[28],"ZD1839":[30,154,206,265,324,428],"(gefitinib),":[31],"small":[33,98],"molecule":[34,99],"EGFR-selective":[35],"tyrosine":[36,103,113],"kinase":[37,104,395],"inhibitor,":[38],"are":[39,482],"advanced":[41],"clinical":[42],"development.":[43],"potential":[45,473],"emergence":[46],"of":[47,61,63,88,120,158,166,200,203,215,232,250,276,360,368,400,403,438,449,455,469],"cell":[49,91,137,172,328,344],"resistance":[50],"EGFR-expressing":[52],"cancers":[53],"treated":[54,151,289,300],"with":[55,153,238,264,278,285,290,301,311,320,323,347,406,424,441],"could":[58],"determine":[59],"lack":[60],"activity":[62,110,119,257],"these":[64,343],"drugs":[65],"some":[67],"patients.":[69],"Vascular":[70],"endothelial":[71,90],"(VEGF)":[74],"secreted":[76],"by":[77,162,176,422,433,462],"cells":[79,386],"plays":[81],"key":[83],"role":[84],"the":[86,188,213,247,358,361,398,447],"regulation":[87],"tumor-induced":[89],"proliferation":[92],"permeability.":[94],"ZD6474":[95,124,239,256],"VEGF":[100,404,470],"flk-1/KDR":[101],"(VEGFR-2)":[102],"inhibitor":[105],"that":[106,467,481],"also":[107,259],"demonstrates":[108],"inhibitory":[109],"against":[111],"kinase.":[114,380],"EXPERIMENTAL":[115],"DESIGN:":[116],"antitumor":[118],"ZD1839,":[121],"C225,":[122],"was":[125,160,174,258,271,295,306,338,418,430],"tested":[126],"athymic":[128],"mice":[129,150,233,262,281,299,309,417],"bearing":[130,234],"human":[131],"GEO":[132,136,146,209,236,269,292,315,349,407,439],"colon":[133],"xenografts.":[135],"lines":[138,329,345],"resistant":[139,483],"to":[140,220,253,484],"were":[143,182,194,282,325],"established":[144,235,326],"from":[145],"xenografts":[147,237,414,440],"growing":[148,317],"chronically":[152],"or":[155,205,266,288,313,322,377,427],"C225.":[156,267],"Expression":[157,165],"evaluated":[161,183],"flow":[163],"cytometry.":[164],"various":[167],"proteins":[168],"intracellular":[171],"assessed":[175],"Western":[177,351],"blotting.":[178],"Tumor":[179],"data":[181,465],"for":[184,246],"statistical":[185],"significance":[186],"using":[187],"Student's":[189],"t":[190],"test.":[191],"All":[192],"Ps":[193],"two-sided.":[195],"RESULTS:":[196],"Although":[197],"chronic":[198],"administration":[199],"optimal":[201],"doses":[202],"efficiently":[207,431],"blocked":[208,296],"tumor":[210,243,293,304],"majority":[214],"mice,":[216],"tumors":[217,316,458,480],"slowly":[218],"started":[219],"grow":[221],"within":[222],"80-90":[223],"days,":[224],"despite":[225],"continuous":[226,230],"treatment.":[227],"In":[228],"contrast,":[229],"treatment":[231,277,319,423,437],"resulted":[240],"efficient":[242],"inhibition":[245,468],"entire":[248],"duration":[249],"dosing":[251],"(up":[252],"150":[254],"days).":[255],"determined":[260],"pretreated":[263],"When":[268],"apparent":[272],"after":[273],"4":[274],"weeks":[275],"inhibitors,":[280],"either":[283,425],"re-treated":[284,310],"ZD6474.":[291,434,463],"only":[297,339],"ZD6474,":[302],"whereas":[303],"progression":[305],"observed":[307],"ZD1839.":[314],"during":[318],"(GEO-C225-RES":[330],"GEO-ZD1839-RES,":[332],"respectively).":[333],"Cell":[334],"membrane-associated":[335],"expression":[337,359,399],"slightly":[340],"reduced":[341],"compared":[346,405],"parental":[348],"cells.":[350,408,453],"blotting":[352],"revealed":[353],"no":[354],"major":[355],"change":[356],"ligand":[363],"transforming":[364],"alpha":[367],"bcl-2,":[369],"bcl-xL,":[370],"p53,":[371],"p27,":[372],"MDM-2,":[373],"akt,":[374],"activated":[375,392],"phospho-akt,":[376],"mitogen-activated":[378],"protein":[379,394],"However,":[381],"both":[382],"GEO-C225-RES":[383,409],"GEO-ZD1839-RES":[385,411],"exhibited":[387],"5-10-fold":[389],"increase":[390],"phospho-mitogen-activated":[393],"cyclooxygenase-2":[401],"nude":[416],"not":[419],"significantly":[420],"affected":[421],"but":[429],"inhibited":[432,461],"CONCLUSIONS:":[435],"Long-term":[436],"selective":[442],"results":[445],"inhibitor-resistant":[451,457],"Growth":[454],"can":[459],"be":[460],"These":[464],"indicate":[466],"has":[472],"an":[475],"anticancer":[476],"strategy,":[477],"even":[478],"EGF":[485],"inhibitors.":[486]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":10},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":9},{"year":2019,"cited_by_count":8},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":14},{"year":2016,"cited_by_count":10},{"year":2015,"cited_by_count":14},{"year":2014,"cited_by_count":17},{"year":2013,"cited_by_count":9},{"year":2012,"cited_by_count":20}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}